Qi Xing (岐星)岐星
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 山东华鲁制药有限公司Chinese legal name: 山东华鲁制药有限公司
主要成分Active Ingredients
- 替加氟Tijia Fu
药物知识说明
替加氟是一种在国家药监局注册认定的药品。该药品含有替加氟-82d83c49等成分。
该药品关联的活性成分包括：替加氟Tijia Fu。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：山东华鲁制药有限公司Chinese legal name: 山东华鲁制药有限公司。
您可以探索含有相同成分的其他药品：替加氟-82d83c49成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 岐星) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 替加氟Tijia Fu.
Manufacturers recorded for this product: 山东华鲁制药有限公司Chinese legal name: 山东华鲁制药有限公司.
Explore other medicines containing the same ingredient: 替加氟 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 岐星Recorded Chinese name: 岐星
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 100ml:替加氟0.5g与氯化钠0.9gRecorded Chinese specification: 100ml:替加氟0.5g与氯化钠0.9g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 山东华鲁制药有限公司Chinese legal name: 山东华鲁制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20030362
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20030362
Manufacturer
Chinese legal name: 山东华鲁制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20030362
生产企业
山东华鲁制药有限公司(国产)
适应症
主要用于治疗消化道肿瘤，如胃癌、直肠癌、胰腺癌、肝癌,亦可用于乳腺癌。
用法用量
?单药成人一日剂量800～1000mg或按体重一次15～20mg/kg，以40～50滴/分的速度静脉滴注，一日1次，总量20～40kg为一疗程.
不良反应
1.骨髓抑制反应轻,有白细胞、血小板下降。|2.神经毒性反应有关痛、眩晕、共济失调、精神状态改变等。少数病人恶心、呕吐、腹泻、肝肾功能改变。|3.局部注射部位有静脉炎、肿胀和疼痛。|4.偶见发热、皮肤瘙痒、色素沉着。
禁忌
尚不明确
注意事项
定期查血象、肝肾功能,异常时根据程度减量或停药.本品注射液禁与酸性药物配伍.
贮藏
遮光、密闭阴凉处保存。
规格
100ml:替加氟0.5g与氯化钠0.9g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.